Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
1980 1
1986 1
1989 1
1994 4
1995 1
1997 2
1998 1
2000 1
2001 3
2002 2
2004 1
2006 1
2007 4
2008 2
2009 2
2010 2
2011 6
2012 6
2013 3
2014 5
2015 2
2016 3
2017 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group.
Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, Au HJ, Murawa P, Walde D, Wolff RA, Campos D, Lim R, Ding K, Clark G, Voskoglou-Nomikos T, Ptasynski M, Parulekar W; National Cancer Institute of Canada Clinical Trials Group. Moore MJ, et al. Among authors: murawa p. J Clin Oncol. 2007 May 20;25(15):1960-6. doi: 10.1200/JCO.2006.07.9525. Epub 2007 Apr 23. J Clin Oncol. 2007. PMID: 17452677 Corrected and republished. Clinical Trial.
Breast cancer: Actual methods of treatment and future trends.
Murawa P, Murawa D, Adamczyk B, Połom K. Murawa P, et al. Rep Pract Oncol Radiother. 2014 Jan 23;19(3):165-72. doi: 10.1016/j.rpor.2013.12.003. eCollection 2014 May. Rep Pract Oncol Radiother. 2014. PMID: 24936340 Free PMC article. Review.
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group.
Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, Au HJ, Murawa P, Walde D, Wolff RA, Campos D, Lim R, Ding K, Clark G, Voskoglou-Nomikos T, Ptasynski M, Parulekar W. Moore MJ, et al. Among authors: murawa p. J Clin Oncol. 2023 Oct 20;41(30):4714-4720. doi: 10.1200/JCO.22.02770. J Clin Oncol. 2023. PMID: 37847995
Transcript level of AKR1C3 is down-regulated in gastric cancer.
Frycz BA, Murawa D, Borejsza-Wysocki M, Wichtowski M, Spychała A, Marciniak R, Murawa P, Drews M, Jagodziński PP. Frycz BA, et al. Among authors: murawa p. Biochem Cell Biol. 2016 Apr;94(2):138-46. doi: 10.1139/bcb-2015-0096. Epub 2015 Dec 10. Biochem Cell Biol. 2016. PMID: 27019068
The pharmacokinetics of oral ketoprofen in patients after gastric resection.
Porażka J, Karbownik A, Murawa D, Spychała A, Firlej M, Grabowski T, Murawa P, Grześkowiak E, Szałek E. Porażka J, et al. Among authors: murawa p. Pharmacol Rep. 2017 Apr;69(2):296-299. doi: 10.1016/j.pharep.2016.11.010. Epub 2016 Dec 9. Pharmacol Rep. 2017. PMID: 28178590
Expression of 17β-hydroxysteroid dehydrogenase type 1 in gastric cancer.
Frycz BA, Murawa D, Wysocki-Borejsza M, Marciniak R, Murawa P, Drews M, Jagodziński PP. Frycz BA, et al. Among authors: murawa p. Biomed Pharmacother. 2013 Sep;67(7):651-7. doi: 10.1016/j.biopha.2013.06.012. Epub 2013 Jul 9. Biomed Pharmacother. 2013. PMID: 23916544
53 results